Cassava Sciences | PTIE - Beban Penjualan Dan Administrasi

Harga Saham
1.87
Perubahan Harian
0.08 4.47%
Bulanan
-23.67%
Tahunan
-33.21%
Q1 Perkiraan
1.74




Beban Penjualan Dan Administrasi Perubahan Tanggal
Abbott USD 3.13B 125M 2025-12
Amgen USD 1.94B 237M 2025-12
Biogen USD 545.2M 38.6M 2025-09
Cara Therapeutics USD 4.64M 2.19M 2025-03
Cassava Sciences USD 6.66M 1.24M 2025-12
Eisai JPY 111.72B 7.86B 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Geron USD 41.67M 2.67M 2025-12
J&J USD 6.75B 831M 2025-12
Merck USD 2.85B 215M 2025-12
Novartis USD 3.44B 128M 2025-12
Novavax USD 25.53M 1.34M 2025-12
Pfizer USD 4.08B 894M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12